In the News

483 News Items found
Breast cancer patient Mikaela Rix
Mikaela’s Story: Facing Breast Cancer as a Woman in Her 20s
Former college lacrosse player Mikaela Rix, diagnosed at age 26, accessed a wide range of resources offered by MSK’s new program tailored for young women with breast cancer.
A woman receives a mammogram, and two technicians help her.
Shorter Version of MRI Plays New Role in Breast Cancer Detection
Researchers from Memorial Sloan Kettering Cancer Center (MSK), in collaboration with an international research team and the ECOG-ACRIN Cancer Research Group, have found that abbreviated breast magnetic resonance imaging (MRI) detected more cancers than digital breast tomosynthesis (3-D mammography) in average-risk women with dense breast tissue.
Q&A
medical oncologist Larry Norton
Some Women with Early Breast Cancer May Not Need Chemotherapy, Study Says
The findings will change how women with intermediate-risk breast cancer are treated.
Bowl of lemons, onion, orange, and red peppers.
Breast Cancer, Food, and Diet: Tips From an MSK Expert
Learn diet and food tips that can lower the risk of breast cancer and potentially improve the outcome if cancer is diagnosed, from Neil Iyengar, an expert on diet and cancer at Memorial Sloan Kettering.
In the Clinic
MSK patient receiving chemotherapy
6 Breakthroughs That Are Changing Chemotherapy for People with Breast Cancer
Discover some of the latest innovations in chemotherapy for breast cancer.
Finding
MSK Physician-in-Chief José Baselga presents at the ASCO meeting
Targeted Therapy Slows Growth of Most Common Type of Advanced Breast Cancer
A clinical trial provides evidence that blocking a protein called PI3K can be an effective treatment strategy for breast cancer.
Selfie of Stephanie Soto-Vega with her husband Eduardo and daughter Luna
She Couldn’t Afford Metastatic Breast Cancer Treatment: How MSK Helped
Learn what can be done for patients like Stephanie Soto-Vega who confront financial hardships caused by cancer.
Feature
A woman considering birth control pills
Birth Control and Cancer Risk: 6 Things You Should Know
Find out what an MSK gynecologist thinks you should know about birth control and cancer risk.
In the Clinic
Illustration of breast cancer cell
Targeted Drug Shows Promise Against HER2-Positive Breast Cancer That Stops Responding to Other Drugs
MSK medical oncologist Shanu Modi is the lead author of a new paper detailing the results from a phase II trial of a breast cancer drug called trastuzumab deruxtecan or DS-8201a. Results from this study were also presented at the San Antonio Breast Cancer Symposium.
Article
MSK medical oncologist Komal Jhaveri.
Imlunestrant With or Without Abemaciclib Effective in Treating ER+, HER2- Advanced Breast Cancer That Resists Standard Therapy
Read about a new treatment for people with some ER+, HER2- advanced breast cancers.